back to Directory

BioAge Labs

BioAge Labs logo

Website
http://bioagelabs.com/
Founded
2015
Patents
7
Clinical Trials
4
Publications
14

Technologies

AI Companies (Drug Discovery) Aging Research

BIOAGE develops drugs to treat aging and its associated diseases. We are backed by Andreessen Horowitz, AME Cloud Ventures, PEAR Ventures, Felicis Ventures, Caffeinated Capital, and others. We have created a unique computational platform that leverages proprietary omics data from large human cohorts to identify the molecular pathways that influence longevity. We then develop drugs that target these pathways and treat specific age-related diseases.

aging biomarkers

Posts Mentioning This Company

Key Trends in Aging Research: Where Are We Now?

  
Over the past decade, aging research has transitioned from foundational biological studies, including a landmark introduction of 9 hallmarks of aging back in 2013 and its expanded version of 12 hallmarks in 2023, to a highly technical, multidisciplinary field. This transformation has been driven by a lot of advances in …

Building Momentum for Global AI-driven Longevity Transformation

  
Today, Insilico Medicine, a leading player in artificial intelligence (AI)-driven drug discovery and longevity research, tops up its recent $60 million Series D with additional $35 million from Prosperity7 Ventures, a global VC fund by Saudi Arabia’s giant Aramco. This investment by Aramco is yet another step within Saudi Arabia’s …

A Running List Of Covid-19 Treatments In Development (Not Updated)

  
Disclaimer: This post is not medical advice, it is only for informational purposes. In case of need, consult your doctor at all times to make decisions about your health. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is a positive …